INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 January 2012
|
Total net assets |
£114.7m |
|
NAV per share |
206.5p |
|
Share price |
175.9p |
|
Total value of unquoted investments |
£18.2m |
|
Total number of portfolio companies |
68 |
|
Cash |
4% NAV |
|
Cash committed and reserved to unquoted investments |
(7)% NAV |
|
Portfolio companies with < 1 year of cash |
11.99% NAV |
Top Ten Holdings
|
Company Name |
% NAV |
|
Micromet |
5.1 |
|
Teva |
4.6 |
|
Gilead Sciences |
4.1 |
|
Amgen |
3.8 |
|
Insulet |
3.8 |
|
Celgene Alexion Pharmaxis |
3.2 3.1 2.9 |
|
Aptiv Shire |
2.8 2.7 |
|
|
----------- |
|
Total |
36.1 |
|
Geographical Allocation |
% |
|
United States |
74 |
|
Europe |
14 |
|
Israel |
5 |
|
Australia |
3 |
|
Cash |
4 |
|
|
----------- |
|
Total |
100 |
|
Quoted/Unquoted allocation |
% |
|
Quoted |
80 |
|
Unquoted |
16 |
|
Cash |
4 |
|
|
----------- |
|
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
17 FEBRUARY 2012